首页|基于有氧糖酵解调节的纳米药物递送系统用于肿瘤治疗的研究进展

基于有氧糖酵解调节的纳米药物递送系统用于肿瘤治疗的研究进展

扫码查看
肿瘤是严重威胁人类健康的难题之一。常用的肿瘤治疗手段均存在一定的局限性,治疗效果不佳,亟待开发新的抗肿瘤策略。在有氧条件下,肿瘤细胞利用糖酵解产生能量的过程称为有氧糖酵解。有氧糖酵解与肿瘤生长、增殖和转移联系密切,为肿瘤治疗提供了新的靶点。纳米药物递送系统因具有可靶向给药、提高疗效和降低毒副作用等优势,被广泛用于靶向肿瘤治疗研究。大量研究表明,越来越多的纳米药物递送系统可通过靶向肿瘤有氧糖酵解过程的信号因子、反应产物等潜在靶点调节有氧糖酵解代谢,进而提升抗肿瘤作用。本文综述了纳米药物递送系统在调节肿瘤有氧糖酵解中的应用,为实现肿瘤的高效靶向治疗提供理论参考。
Research progress of nanomedical drug delivery system based on aerobic glycolytic regulation for tumor therapy
Tumor is one of the serious problems threatening human health.There are some limitations in the delivery of commonly used tumor therapy technologies,and the therapeutic effect is not satisfactory,so new anti-tumor strategies need to be developed.The process of tumor cells using glycolysis to produce energy under aerobic conditions is called aerobic glycolysis,which is closely related to tumor growth,proliferation and metastasis,and can provide a new target spot for tumor treatment.Nano drug delivery system has been widely used in targeted tumor therapy because of its advantages of targeted drug delivery,improved anti-tumor efficacy and reduced toxic side effects.Numerous studies have shown that more and more nano drug delivery systems regulates aerobic glycolytic metabolism by targeting to potential targets such as signaling factors or reaction products of aerobic glycolytic process in tumors,and therefore enhance the anti-tumor effect.This paper reviews the application of nano drug delivery system in regulating tumor aerobic glycolysis,and provides theoretical references for realizing efficient targeted tumor therapy.

aerobic glycolysisnano drug delivery systemtumor therapycombined therapy

李一菁、黄胜楠、王子昂、直炜炜、祝侠丽

展开 >

河南中医药大学药学院,河南郑州 450046

河南中医药大学中医药科学院,河南郑州 450046

河南中医药大学豫药全产业链研发河南省协同创新中心,河南郑州 450046

有氧糖酵解 纳米药物递送系统 肿瘤治疗 联合治疗

2024

药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
年,卷(期):2024.59(9)